Registry for collecting data on adult Acute Lymphoblastic Leukemia patients
Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult ALL Patients and Related Diseases Associated With a Prospective Collection of Biomaterial
This study is collecting information from adults with Acute Lymphoblastic Leukemia to see how well different treatments work and to improve care for future patients.
Quick facts
| Study type | Observational |
|---|---|
| Enrollment | 10000 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Goethe University Academic / other |
| Locations | 152 sites (Graz and 151 other locations) |
| Trial ID | NCT02872987 on ClinicalTrials.gov |
What this trial studies
This registry collects prospective data on the diagnosis, treatment, and outcomes of adult patients with Acute Lymphoblastic Leukemia (ALL) and related diseases. It aims to improve research and quality assurance in the management of ALL by gathering information from clinical routines, regardless of whether patients are part of a clinical trial. The data collected will help in understanding treatment efficacy and patient outcomes over time.
Who should consider this trial
Good fit: Ideal candidates for this registry are adults aged 18 and older diagnosed with Acute Lymphoblastic Leukemia or specific types of Non-Hodgkin's Lymphoma treated according to established protocols.
Not a fit: Patients with leukemia types not treated according to the specified protocols or those under 18 years old may not benefit from this registry.
Why it matters
Potential benefit: If successful, this registry could enhance treatment strategies and improve outcomes for patients with Acute Lymphoblastic Leukemia.
How similar studies have performed: Other studies utilizing registries for data collection in hematological malignancies have shown success in improving patient outcomes and treatment protocols.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Acute Lymphoblastic Leukemia (All Subtypes) if treated according to ALL protocols * Other Types of Leukemia (NK Cell Lymphoma/Leukemia, Biphenotypic Acute Leukemia) if treated according to ALL protocols * Non-Hodgkin's Lymphoma of Following Subtypes: Burkitt Lymphoma, B Cell Lymphoma, B- or T-lineage Lymphoblastic Lymphoma, Anaplastic Large Cell Lymphoma, Other NHL) if treated according to B-ALL protocols * Age minimum 18 yrs
Where this trial is running
Graz and 151 other locations
- Universitätsklinikum Graz — Graz, Austria (Recruiting)
- LKH-Hochsteiermark Leoben — Leoben, Austria (Recruiting)
- Hanusch-Krankenhaus Wien — Vienna, Austria (Recruiting)
- University Hospital of Frankfurt (Main) — Frankfurt am Main, Hesse, Germany (Recruiting)
- Universitätsklinikum Aachen — Aachen, Germany (Recruiting)
- Klinikum Altenburger Land — Altenburg, Germany (Recruiting)
- Kreiskliniken Altötting — Altötting, Germany (Recruiting)
- Klinikum Aschaffenburg — Aschaffenburg, Germany (Recruiting)
- Klinikum Augsburg — Augsburg, Germany (Recruiting)
- Helios Klinikum Bad Saarow — Bad Saarow, Germany (Recruiting)
- Sozialstiftung Bamberg — Bamberg, Germany (Recruiting)
- Klinikum Bayreuth — Bayreuth, Germany (Recruiting)
- Alexianer St. Hedwig Krankenhaus — Berlin, Germany (Recruiting)
- Charité Universitätsmedizin Berlin — Berlin, Germany (Recruiting)
- Evangelisches Waldkrankenhaus Spandau — Berlin, Germany (Recruiting)
- Helios Klinikum Berlin-Buch — Berlin, Germany (Recruiting)
- Vivantes Klinikum Neukölln — Berlin, Germany (Recruiting)
- Vivantes-Klinikum am Urban — Berlin, Germany (Recruiting)
- Evangelisches Krankenhaus Bielefeld — Bielefeld, Germany (Recruiting)
- Franziskus-Hospital Bielefeld — Bielefeld, Germany (Recruiting)
- Klinikum Bielefeld — Bielefeld, Germany (Recruiting)
- Augsuta Krankenanstalt Bochum — Bochum, Germany (Recruiting)
- Katholisches Klinikum Bochum — Bochum, Germany (Recruiting)
- Universitätsklinikum Knappschaftskrankenhaus Bochum — Bochum, Germany (Recruiting)
- Johanniter-Krankenhaus Bonn — Bonn, Germany (Recruiting)
- Universitätsklinikum Bonn — Bonn, Germany (Recruiting)
- Städtisches Klinikum Braunschweig — Braunschweig, Germany (Recruiting)
- Evangelische Diakonissenanstalt Bremen — Bremen, Germany (Recruiting)
- Klinikum Bremen-Mitte gGmbH — Bremen, Germany (Recruiting)
- Klinikum Chemnitz gGmbH — Chemnitz, Germany (Recruiting)
- Universitätsklinikum Köln — Cologne, Germany (Recruiting)
- Carl-Thiem-Klinikum Cottbus — Cottbus, Germany (Recruiting)
- Klinikum Darmstadt — Darmstadt, Germany (Recruiting)
- Städtisches Krankenhaus Dessau — Dessau, Germany (Recruiting)
- Klinikum Dortmund — Dortmund, Germany (Recruiting)
- St. Johannes-Hospital Dortmund — Dortmund, Germany (Recruiting)
- Klinikum Carl-Gustav-Carus — Dresden, Germany (Recruiting)
- Städtisches Klinikum Dresden — Dresden, Germany (Recruiting)
- Helios Klinikum Duisburg — Duisburg, Germany (Recruiting)
- Johanniter-Krankenhaus Duisburg — Duisburg, Germany (Recruiting)
- Krankenhaus Düren — Düren, Germany (Recruiting)
- Marien-Hospital Düsseldorf — Düsseldorf, Germany (Recruiting)
- Universitätsklinikum Düsseldorf — Düsseldorf, Germany (Recruiting)
- Helios Klinikum Erfurt — Erfurt, Germany (Recruiting)
- Universitätsklinikum Erlangen — Erlangen, Germany (Recruiting)
- St.-Antonius-Hospital Eschweiler — Eschweiler, Germany (Recruiting)
- Evang. Krankenhaus Essen-Werden — Essen, Germany (Recruiting)
- Universitätsklinikum Essen — Essen, Germany (Recruiting)
- Klinikum Esslingen — Esslingen am Neckar, Germany (Recruiting)
- Malteser Krankenhaus Flensburg — Flensburg, Germany (Recruiting)
+102 more sites — see ClinicalTrials.gov for the full list.
Study contacts
- Principal investigator: Nicola Gökbuget, Dr. med. — University Hospital of Frankfurt (Main)
- Study coordinator: Nicola Gökbuget, Dr. med.
- Email: goekbuget@em.uni-frankfurt.de
- Phone: +496963016365
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.